which was the company’s Dermasys gel technology without the glycerile trinitrate ingredient. The company believes MED3000 could have an advantage over approved erectile dysfunction drugs such as ...
Just over a month after getting FDA approval for the first over-the-counter (OTC) topical therapy for erectile dysfunction ... US rights to commercialise the gel-based product, called MED3000 ...
However, due to close proximity, nearby healthy organs can be affected resulting in side effects including rectal bleeding, erectile dysfunction, bowel and bladder damage. The liquid gel spacer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results